DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens
DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...
MODI is the first FDA-cleared solution to use glucose-monitoring data to automatically optimize insulin dosing for people with type 2 diabetes across both basal-only and multiple daily injection ...
You can naturally prevent or reduce insulin resistance with diet and lifestyle changes. Strategies like eating more fiber and ...
The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly ...
Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin efsitora ...
The FDA has granted 510(k) clearance for an insulin titration algorithm that uses continuous glucose monitoring and insulin ...
People with type 2 diabetes (T2D) who began using continuous glucose monitoring (CGM) while receiving basal insulin had a 44% ...
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...
Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty of ...
Regular insulin injections can be an essential part of managing Type 2 diabetes. But many people find daily injections to be bothersome or inconvenient. That's where once-a-week insulin can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results